Ravi Mohanka

Dr. Ravi Mohanka

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
ABAmay Banker
Amay Banker
NBNeha Bhatt
Neha Bhatt
PRPrashantha S. Rao
Prashantha S. Rao
PAPravin Agrawal
Pravin Agrawal
MSMitul Shah
Mitul Shah
RMRavi Mohanka
Ravi Mohanka

1 July 2021 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
RMRavi Mohanka
Ravi Mohanka
PRPrashantha Rao
Prashantha Rao
MSMitul Shah
Mitul Shah
AGAmit Gupte
Amit Gupte
VNVinayak Nikam
Vinayak Nikam
SSSamir Shah
Samir Shah

1 July 2021 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
MRMettu S. Reddy
Mettu S. Reddy
ARAkila Rajakumar
Akila Rajakumar
JMJohns S. Mathew
Johns S. Mathew
LVL. Venkatakrishnan
L. Venkatakrishnan
DJDinesh Jothimani
Dinesh Jothimani
SSShiv K. Sarin
Shiv K. Sarin

13 May 2022 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
SGSubash Gupta
Subash Gupta
MSManisha Sahay
Manisha Sahay
BRBala Ramachandran
Bala Ramachandran
AKAnil Kumar
Anil Kumar
RGRoop Gursahani
Roop Gursahani
RMRaj K Mani
Raj K Mani
Organ donation following circulatory determination of death (DCDD) has contributed significantly to the donor pool in several countries. In India, majority of deceased donations happen following brain death (BD). While existing legislation allows for DCDD, there have been only few reports of kidney transplantation following DCDD from India. This document, prepared by a multidisciplinary group of experts, reviews international best practices in DCDD and outlines the path for DCDD in India. Ethical, medical, legal, economic, procedural, and logistic challenges unique to India have been addressed. The practice of withdrawal of life-sustaining treatment (WLST) in India, laid down by the Supreme Court of India, is time-consuming, possible only in patients in a permanent vegetative state, and too cumbersome for day-to-day practice. In patients where continued medical care is futile, the procedure for WLST is described. In controlled DCDD (category-III), decision for WLST is independent of and delinked from the subsequent possibility of organ donation. Families that are inclined toward organ donation are explained the procedure including the timing and location of WLST, consent for antemortem measures, no-touch period, and the possibility of stand-down and return to the intensive care unit (ICU) without donation. In donation following neurologic determination of death (DNDD), if cardiac arrest occurs during the process of BD declaration, the protocol for DCDD category-IV has been described in detail. In DCDD category-V, organ donation may be possible following unsuccessful cardiopulmonary resuscitation of cardiac arrest in the ICU. An outline of organ-specific requisites for kidney, liver, heart, and lung transplantation following DCDD and techniques, such as normothermic regional perfusion (nRP) and ex vivo machine perfusion, has been provided. The outcomes of transplantation following DCDD are comparable to those following DBDD or living donor transplantation. Documents and checklists necessary for successful execution of DCDD in India are described.

22 October 2019 in BMC Surgery
Verified
Journal Article
Open access
PDF file
NVNikam Vinayak
Nikam Vinayak
RMRavi Mohanka
Ravi Mohanka
GAGolhar Ankush
Golhar Ankush
BRBhade Rashmi
Bhade Rashmi
RPRao Prashantha
Rao Prashantha
SAShrimal Anurag
Shrimal Anurag
Background: Living donor liver transplantation (LDLT) has emerged as an equally viable option to deceased donor liver transplant for treating end stage liver disease patients. Optimising the recipient outcome without compromising donor safety is the primary goal of LDLT. Achieving the adequate graft to recipient weight ratio (GRWR) is important to prevent small for size syndrome which is an uncommon but potentially lethal complication of LDLT. Case presentation: Here we describe a case of successful dual lobe liver transplant for a 32 years old patient with ethanol related end stage liver disease. A right lobe graft without middle hepatic vein and another left lateral sector graft were transplanted successfully. Recipient and both donors recovered uneventfully. Conclusion: Dual lobe liver transplant is a feasible strategy to achieve adequate GRWR without compromising donor safety.

1 July 2010 in Surgery
Verified
Journal Article
Closed access
ASArvinder Soin
Arvinder Soin
VKVinay Kumaran
Vinay Kumaran
RMRavi Mohanka
Ravi Mohanka
NMNaimish Mehta
Naimish Mehta
NMNeelam Mohan
Neelam Mohan
SNSamiran Nundy
Samiran Nundy